Officer and Director Sale of Shares

Nathan L. Mata, Chief Scientific Officer of BELITE BIO, INC, reported the sale of American depositary shares on April 30, 2026. The sales were executed under a Rule 10b5-1 trading plan. A total of 950 shares were sold in multiple transactions. The first transaction involved 42 shares sold at a weighted average price of $155.68. The second transaction involved 517 shares sold at a weighted average price of $156.59. The third transaction involved 340 shares sold at a weighted average price of $157.37. The final transaction involved 101 shares sold at a weighted average price of $158.15. Following these transactions, Mr. Mata directly owns 4,666 American depositary shares.